Your session is about to expire
← Back to Search
Genetic Testing Education for Cancer Risk (GeneBOPP Trial)
N/A
Waitlist Available
Led By Huma Rana, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
Summary
This trial is testing whether two different ways of providing information to people considering genetic testing for cancer risk affects how likely they are to get the test.
Who is the study for?
This trial is for adults over 18 with breast, ovarian, pancreatic, or metastatic prostate cancer who haven't had genetic testing for cancer before. They must understand English well enough to consent and can't be pregnant or imprisoned.Check my eligibility
What is being tested?
The study compares two ways of educating people about genetic testing for hereditary cancers: one group will receive standard genetic counseling and the other will watch an educational video.See study design
What are the potential side effects?
Since this trial involves education methods rather than medical treatments, there are no direct side effects from interventions like drugs or surgery. However, learning about cancer risks may cause emotional or psychological impact.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of patients who have germline genetic tests
Secondary outcome measures
Cascade testing in positives
Decisional Regret
Family communication of genetic test results
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group B: Educational videoExperimental Treatment1 Intervention
Will watch a brief educational video that is approximately 8 minutes in length about the genetic testing process and what to expect prior to genetic testing.
Group II: Group A: Standard genetic counselingActive Control1 Intervention
Will receive standard genetic counseling prior to genetic testing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Video
2013
N/A
~1530
Find a Location
Who is running the clinical trial?
Dana-Farber Cancer InstituteLead Sponsor
1,085 Previous Clinical Trials
341,511 Total Patients Enrolled
40 Trials studying Ovarian Cancer
4,383 Patients Enrolled for Ovarian Cancer
Ambry GeneticsIndustry Sponsor
3 Previous Clinical Trials
485 Total Patients Enrolled
Huma Rana, MD5.05 ReviewsPrincipal Investigator - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
5Patient Review
Dr. Rana is an excellent caretaker, especially for those with a genetic disposition for cancer. She is very knowledgeable and takes her time with each patient to ensure they feel comfortable and confident.
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a known blood cancer, such as chronic lymphocytic leukemia (CLL).You have breast, ovarian, pancreatic, or advanced prostate cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Group B: Educational video
- Group 2: Group A: Standard genetic counseling
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger